Source: Xinhua | 2026-08-07 | Editor:Flynn

A staff member trains a robot to arrange items in a supermarket scenario at Maniformer, a physical AI data service platform, in Shanghai, east China, Aug. 5, 2026. (Xinhua/Liu Ying)
Robots, AI-related products and innovative drugs are emerging as new drivers of China's export growth, as the country expands into higher-value industries driven by innovation.
In July, the country's exports rose 17.8 percent year on year, with high-tech products, including industrial robots and 3D printers, contributing nearly 60 percent of the total increase in exports, data from the General Administration of Customs showed on Friday.
Exports of industrial robots jumped 13.2 percent to 7.34 billion yuan (about 1.1 billion U.S. dollars) last month. This trend builds on the momentum from 2025, when China became a net exporter of industrial robots for the first time.
Beyond industrial robots, Chinese-made consumer and humanoid robots are also finding widespread applications in manufacturing and everyday life around the world.
Official data showed that in the first half of this year, exports of surgical robots climbed 3.3-fold year on year to 480 million yuan, while exports of cleaning robots and intelligent bionic robots, including humanoid robots, robotic dogs and biomimetic fish and birds, reached 18.09 billion yuan.
AI-related exports also gained momentum. In the January-June period, exports of electronic components and computer parts both posted double-digit growth, contributing a combined 6.9 percentage points to overall export growth.
Beyond manufactured goods, China's technology exports now extend to digital services, with companies increasingly providing AI algorithms, cloud computing, and digital solutions to overseas markets. OpenRouter, a global platform that aggregates large language models, said that all of the six most-used models on its platform in July were open-source models developed in China.
The shift is also visible in the pharmaceutical industry, where Chinese companies are increasingly taking their innovations global through licensing deals for new drugs.
In the first half, Chinese companies signed 81 outbound licensing agreements for innovative drugs with partners in 20 countries and regions, including the United States, Britain, France and Italy. The total deal value reached 80 percent of the full-year figure for 2025.
China now accounts for about 30 percent of the world's new drugs under development, ranking second globally, according to the National Medical Products Administration. ■
While navigating a mountain road near Yingjing county in Sichuan province in late July, Le Weiqiang got news that made him pull over and turn the car around: An...
The three astronauts from China's Shenzhou-21 crewed mission met the press in Beijing on Wednesday, their first public appearance after returning to Earth in Ma...
Chinese-made electric vehicles are rapidly gaining ground in South Korea, showing the competitiveness and export resilience of China's EV supply chain as consum...
As shadows of tree leaves drift across the gray-brick walls of Liuchi Alley in Tongcheng City, east China's Anhui Province, visitors take photos along the narro...
China has released a mandatory national standard regarding safety requirements for autonomous driving systems, the Ministry of Industry and Information Technolo...
As a summer heat wave bakes much of the Northern Hemisphere, travelers are fleeing sweltering cities in search of cooler escapes, with China's high-altitude pla...
A Chinese defense spokesperson on Tuesday refuted contents related to the Chinese military in Japan's new defense white paper, noting that it is hyping up the s...
A Smart Dragon-3 carrier rocket lifted off from the waters off east China's Shandong Province on Wednesday, sending Oriental Smart Eye hyperspectral satellites ...
A powerful typhoon churning across the western Pacific Ocean could threaten China's eastern coastline later this week, as meteorologists warned that August is l...